Literature DB >> 23051844

Cancer stem cell definitions and terminology: the devil is in the details.

Peter Valent1, Dominique Bonnet, Ruggero De Maria, Tsvee Lapidot, Mhairi Copland, Junia V Melo, Christine Chomienne, Fumihiko Ishikawa, Jan Jacob Schuringa, Giorgio Stassi, Brian Huntly, Harald Herrmann, Jean Soulier, Alexander Roesch, Gerrit Jan Schuurhuis, Stefan Wöhrer, Michel Arock, Johannes Zuber, Sabine Cerny-Reiterer, Hans E Johnsen, Michael Andreeff, Connie Eaves.   

Abstract

The cancer stem cell (CSC) concept has important therapeutic implications, but its investigation has been hampered both by a lack of consistency in the terms used for these cells and by how they are defined. Evidence of their heterogeneous origins, frequencies and their genomic, as well as their phenotypic and functional, properties has added to the confusion and has fuelled new ideas and controversies. Participants in The Year 2011 Working Conference on CSCs met to review these issues and to propose a conceptual and practical framework for CSC terminology. More precise reporting of the parameters that are used to identify CSCs and to attribute responses to them is also recommended as key to accelerating an understanding of their biology and developing more effective methods for their eradication in patients.

Entities:  

Mesh:

Year:  2012        PMID: 23051844     DOI: 10.1038/nrc3368

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


  102 in total

Review 1.  A decade of exploring the cancer epigenome - biological and translational implications.

Authors:  Stephen B Baylin; Peter A Jones
Journal:  Nat Rev Cancer       Date:  2011-09-23       Impact factor: 60.716

Review 2.  Targeting Notch to target cancer stem cells.

Authors:  Antonio Pannuti; Kimberly Foreman; Paola Rizzo; Clodia Osipo; Todd Golde; Barbara Osborne; Lucio Miele
Journal:  Clin Cancer Res       Date:  2010-06-08       Impact factor: 12.531

3.  A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth.

Authors:  Alexander Roesch; Mizuho Fukunaga-Kalabis; Elizabeth C Schmidt; Susan E Zabierowski; Patricia A Brafford; Adina Vultur; Devraj Basu; Phyllis Gimotty; Thomas Vogt; Meenhard Herlyn
Journal:  Cell       Date:  2010-05-14       Impact factor: 41.582

Review 4.  Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways.

Authors:  Naoko Takebe; Pamela J Harris; Ronald Q Warren; S Percy Ivy
Journal:  Nat Rev Clin Oncol       Date:  2010-12-14       Impact factor: 66.675

Review 5.  Mobilization of hematopoietic stem cells into the peripheral blood.

Authors:  Lloyd E Damon; Lauren E Damon
Journal:  Expert Rev Hematol       Date:  2009-12       Impact factor: 2.929

6.  A model of human acute lymphoblastic leukemia in immune-deficient SCID mice.

Authors:  S Kamel-Reid; M Letarte; C Sirard; M Doedens; T Grunberger; G Fulop; M H Freedman; R A Phillips; J E Dick
Journal:  Science       Date:  1989-12-22       Impact factor: 47.728

7.  Inhibition of mitochondrial translation as a therapeutic strategy for human acute myeloid leukemia.

Authors:  Marko Skrtić; Shrivani Sriskanthadevan; Bozhena Jhas; Marinella Gebbia; Xiaoming Wang; Zezhou Wang; Rose Hurren; Yulia Jitkova; Marcela Gronda; Neil Maclean; Courteney K Lai; Yanina Eberhard; Justyna Bartoszko; Paul Spagnuolo; Angela C Rutledge; Alessandro Datti; Troy Ketela; Jason Moffat; Brian H Robinson; Jessie H Cameron; Jeffery Wrana; Connie J Eaves; Mark D Minden; Jean C Y Wang; John E Dick; Keith Humphries; Corey Nislow; Guri Giaever; Aaron D Schimmer
Journal:  Cancer Cell       Date:  2011-11-15       Impact factor: 31.743

Review 8.  Targeting stem cells-clinical implications for cancer therapy.

Authors:  Lan Chun Tu; Greg Foltz; Edward Lin; Leroy Hood; Qiang Tian
Journal:  Curr Stem Cell Res Ther       Date:  2009-05       Impact factor: 3.828

Review 9.  Mapping normal and cancer cell signalling networks: towards single-cell proteomics.

Authors:  Jonathan M Irish; Nikesh Kotecha; Garry P Nolan
Journal:  Nat Rev Cancer       Date:  2006-02       Impact factor: 60.716

10.  Identification of selective inhibitors of cancer stem cells by high-throughput screening.

Authors:  Piyush B Gupta; Tamer T Onder; Robert A Weinberg; Eric S Lander; Guozhi Jiang; Kai Tao; Charlotte Kuperwasser
Journal:  Cell       Date:  2009-08-13       Impact factor: 41.582

View more
  287 in total

1.  Isolation of cancer stem cells from human prostate cancer samples.

Authors:  Samuel J Vidal; S Aidan Quinn; Janis de la Iglesia-Vicente; Dennis M Bonal; Veronica Rodriguez-Bravo; Adolfo Firpo-Betancourt; Carlos Cordon-Cardo; Josep Domingo-Domenech
Journal:  J Vis Exp       Date:  2014-03-14       Impact factor: 1.355

Review 2.  Cancer stem cells: involvement in pancreatic cancer pathogenesis and perspectives on cancer therapeutics.

Authors:  Cristiana Pistol Tanase; Ana Iulia Neagu; Laura Georgiana Necula; Cristina Mambet; Ana-Maria Enciu; Bogdan Calenic; Maria Linda Cruceru; Radu Albulescu
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

3.  Notch Signaling Pathway in Pancreatic Cancer Progression.

Authors:  Jia Ma; Jun Xia; Lucio Miele; Fazlul H Sarkar; Zhiwei Wang
Journal:  Pancreat Disord Ther       Date:  2013-05-30

Review 4.  Cancer Stem Cells: The Architects of the Tumor Ecosystem.

Authors:  Briana C Prager; Qi Xie; Shideng Bao; Jeremy N Rich
Journal:  Cell Stem Cell       Date:  2019-01-03       Impact factor: 24.633

5.  Decreased affinity of recombinant human tumor necrosis factor-related apoptosis-inducing ligand (rhTRAIL) D269H/E195R to osteoprotegerin (OPG) overcomes TRAIL resistance mediated by the bone microenvironment.

Authors:  Matthieu C J Bosman; Carlos R Reis; Jan J Schuringa; Edo Vellenga; Wim J Quax
Journal:  J Biol Chem       Date:  2013-11-26       Impact factor: 5.157

6.  Salivary Gland Cancer Patient-Derived Xenografts Enable Characterization of Cancer Stem Cells and New Gene Events Associated with Tumor Progression.

Authors:  Stephen B Keysar; Justin R Eagles; Bettina Miller; Brian C Jackson; Farshad N Chowdhury; Julie Reisinger; Tugs-Saikhan Chimed; Phuong N Le; John J Morton; Hilary L Somerset; Marileila Varella-Garcia; Aik-Choon Tan; John I Song; Daniel W Bowles; Mary E Reyland; Antonio Jimeno
Journal:  Clin Cancer Res       Date:  2018-03-19       Impact factor: 12.531

7.  Functional Subclone Profiling for Prediction of Treatment-Induced Intratumor Population Shifts and Discovery of Rational Drug Combinations in Human Glioblastoma.

Authors:  Roman Reinartz; Shanshan Wang; Sied Kebir; Daniel J Silver; Anja Wieland; Tong Zheng; Marius Küpper; Laurèl Rauschenbach; Rolf Fimmers; Timothy M Shepherd; Daniel Trageser; Andreas Till; Niklas Schäfer; Martin Glas; Axel M Hillmer; Sven Cichon; Amy A Smith; Torsten Pietsch; Ying Liu; Brent A Reynolds; Anthony Yachnis; David W Pincus; Matthias Simon; Oliver Brüstle; Dennis A Steindler; Björn Scheffler
Journal:  Clin Cancer Res       Date:  2016-08-12       Impact factor: 12.531

Review 8.  Cell plasticity and heterogeneity in cancer.

Authors:  Nemanja D Marjanovic; Robert A Weinberg; Christine L Chaffer
Journal:  Clin Chem       Date:  2012-12-06       Impact factor: 8.327

Review 9.  Sinonasal carcinoma: clinical, pathological, genetic and therapeutic advances.

Authors:  José Luis Llorente; Fernando López; Carlos Suárez; Mario A Hermsen
Journal:  Nat Rev Clin Oncol       Date:  2014-06-17       Impact factor: 66.675

Review 10.  Roles of F-box proteins in cancer.

Authors:  Zhiwei Wang; Pengda Liu; Hiroyuki Inuzuka; Wenyi Wei
Journal:  Nat Rev Cancer       Date:  2014-04       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.